BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9814834)

  • 1. Clinical features and genetics of progressive myoclonus epilepsy of the Univerricht-Lundborg type.
    Lehesjoki AE; Koskiniemi M
    Ann Med; 1998 Oct; 30(5):474-80. PubMed ID: 9814834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive myoclonus epilepsy of Unverricht-Lundborg type.
    Lehesjoki AE; Koskiniemi M
    Epilepsia; 1999; 40 Suppl 3():23-8. PubMed ID: 10446747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cystatin B mutation and diagnostic PCR assay in an Unverricht-Lundborg progressive myoclonus epilepsy patient.
    Bespalova IN; Adkins S; Pranzatelli M; Burmeister M
    Am J Med Genet; 1997 Sep; 74(5):467-71. PubMed ID: 9342192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and neurophysiological development of Unverricht-Lundborg disease in four Swedish siblings.
    Kyllerman M; Sommerfelt K; Hedström A; Wennergren G; Holmgren D
    Epilepsia; 1991; 32(6):900-9. PubMed ID: 1743164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1.
    Virtaneva K; D'Amato E; Miao J; Koskiniemi M; Norio R; Avanzini G; Franceschetti S; Michelucci R; Tassinari CA; Omer S; Pennacchio LA; Myers RM; Dieguez-Lucena JL; Krahe R; de la Chapelle A; Lehesjoki AE
    Nat Genet; 1997 Apr; 15(4):393-6. PubMed ID: 9090386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic bases of the progressive myoclonus epilepsies.
    Serratosa JM; Gardiner RM; Lehesjoki AE; Pennacchio LA; Myers RM
    Adv Neurol; 1999; 79():383-98. PubMed ID: 10514828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
    de Haan GJ; Halley DJ; Deelen WH; Lindhout D
    Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unverricht-Lundborg disease (PME1)].
    Genton P
    Rev Neurol (Paris); 2006 Sep; 162(8-9):819-26. PubMed ID: 17028542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset.
    Lalioti MD; Scott HS; Genton P; Grid D; Ouazzani R; M'Rabet A; Ibrahim S; Gouider R; Dravet C; Chkili T; Bottani A; Buresi C; Malafosse A; Antonarakis SE
    Am J Hum Genet; 1998 Apr; 62(4):842-7. PubMed ID: 9529356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).
    Lalioti MD; Mirotsou M; Buresi C; Peitsch MC; Rossier C; Ouazzani R; Baldy-Moulinier M; Bottani A; Malafosse A; Antonarakis SE
    Am J Hum Genet; 1997 Feb; 60(2):342-51. PubMed ID: 9012407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
    Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
    Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic heterogeneity of Mediterranean myoclonus and the cystatin B gene.
    Labauge P; Ouazzani R; M'Rabet A; Grid D; Genton P; Dravet C; Chkili T; Beck C; Buresi C; Baldy-Moulinier M; Malafosse A
    Ann Neurol; 1997 May; 41(5):686-9. PubMed ID: 9153533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive myoclonus epilepsies: clinical and genetic aspects.
    Berkovic SF; Cochius J; Andermann E; Andermann F
    Epilepsia; 1993; 34 Suppl 3():S19-30. PubMed ID: 8500430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1.
    Lafrenière RG; Rochefort DL; Chrétien N; Rommens JM; Cochius JI; Kälviäinen R; Nousiainen U; Patry G; Farrell K; Söderfeldt B; Federico A; Hale BR; Cossio OH; Sørensen T; Pouliot MA; Kmiec T; Uldall P; Janszky J; Pranzatelli MR; Andermann F; Andermann E; Rouleau GA
    Nat Genet; 1997 Mar; 15(3):298-302. PubMed ID: 9054946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive myoclonic ataxia without ragged red fibres: Unverricht-Lundborg disease vs Ramsay Hunt syndrome.
    Shakir RA; Khan RA; al-Zuhair AG
    Acta Neurol Scand; 1992 Nov; 86(5):470-3. PubMed ID: 1336290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myoclonic epilepsies in infancy].
    Palencia R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S15-24. PubMed ID: 10904965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unverricht-Lundborg disease with cystatin B gene abnormalities.
    Kagitani-Shimono K; Imai K; Okamoto N; Ono J; Okada S
    Pediatr Neurol; 2002 Jan; 26(1):55-60. PubMed ID: 11814737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.